학술논문

Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
Document Type
Article
Source
In: Advances in Therapy. (Advances in Therapy, March 2023, 40(3):1267-1281)
Subject
Language
English
ISSN
18658652
0741238X